Nano X Imaging Ltd (NNOX) - Total Liabilities
Based on the latest financial reports, Nano X Imaging Ltd (NNOX) has total liabilities worth $19.46 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore NNOX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Nano X Imaging Ltd - Total Liabilities Trend (2018–2025)
This chart illustrates how Nano X Imaging Ltd's total liabilities have evolved over time, based on quarterly financial data.
Nano X Imaging Ltd Competitors by Total Liabilities
The table below lists competitors of Nano X Imaging Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Johnson Chemical Pharmaceutical Works Co Ltd
TWO:4747
|
Taiwan | NT$279.70 Million |
|
Genohco Inc.
KQ:361390
|
Korea | ₩42.57 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.03 Billion |
|
Coeptis Therapeutics Inc
NASDAQ:COEP
|
USA | $3.26 Million |
|
Engenco Ltd
AU:EGN
|
Australia | AU$94.56 Million |
|
Marchex Inc
NASDAQ:MCHX
|
USA | $9.60 Million |
|
Helius Medical Technologies Inc Class A
NASDAQ:HSDT
|
USA | $628.31 Million |
|
OPAL Fuels Inc
NASDAQ:OPAL
|
USA | $433.95 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Nano X Imaging Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nano X Imaging Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nano X Imaging Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nano X Imaging Ltd (2018–2025)
The table below shows the annual total liabilities of Nano X Imaging Ltd from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $22.43 Million | +7.42% |
| 2024-12-31 | $20.88 Million | -9.73% |
| 2023-12-31 | $23.13 Million | -37.90% |
| 2022-12-31 | $37.25 Million | -47.55% |
| 2021-12-31 | $71.02 Million | +1214.49% |
| 2020-12-31 | $5.40 Million | -73.83% |
| 2019-12-31 | $20.65 Million | +150.63% |
| 2018-12-31 | $8.24 Million | -- |
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source… Read more